S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Sell every Stock except ONE (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
The Financial Day of Reckoning Has Begun (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Sell every Stock except ONE (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
The Financial Day of Reckoning Has Begun (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Sell every Stock except ONE (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
The Financial Day of Reckoning Has Begun (Ad)
S&P 500   4,274.04
DOW   33,980.32
QQQ   328.49
Agilent Technologies Proves Its Worth VS Illumina 
Our Most Important Forecast in 50 Years Tectonic changes are on the way. (Ad)
Target’s Results Cap Upside Potential For Retail Stocks 
Wind energy boom and golden eagles collide in the US West
Lowe’s Stands Out Amid Q2 Retail Reports 
Sell every Stock except ONE (Ad)
Egypt's central bank governor resigns as economic woes mount
Target takes a hit after heavy discounts to clear inventory
Stocks slip on Wall Street, erasing weekly gains for S&P 500
The Financial Day of Reckoning Has Begun (Ad)
NYSE:TDOC

Teladoc Health - TDOC Stock Forecast, Price & News

$35.95
-3.50 (-8.87%)
(As of 08/17/2022 12:00 AM ET)
Add
Compare
Today's Range
$35.90
$38.47
50-Day Range
$28.63
$43.66
52-Week Range
$27.38
$156.82
Volume
6.61 million shs
Average Volume
6.25 million shs
Market Capitalization
$5.79 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$64.83

Teladoc Health MarketRank™ Forecast

Analyst Rating
Hold
2.14 Rating Score
Upside/​Downside
80.3% Upside
$64.83 Price Target
Short Interest
Healthy
18.85% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.58mentions of Teladoc Health in the last 14 days
Based on 12 Articles This Week
Insider Trading
Selling Shares
$221,498 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($1.64) to ($1.29) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.70 out of 5 stars

Medical Sector

92nd out of 1,122 stocks

Offices & Clinics Of Medical Doctors Industry

1st out of 9 stocks

TDOC stock logo

About Teladoc Health (NYSE:TDOC) Stock

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.

Analysts Set New Price Targets

A number of research firms have commented on TDOC. Cowen downgraded shares of Teladoc Health from an "outperform" rating to a "market perform" rating and cut their target price for the stock from $58.00 to $34.00 in a research report on Tuesday, August 2nd. Robert W. Baird cut their target price on shares of Teladoc Health from $72.00 to $64.00 in a research report on Wednesday, April 27th. Argus downgraded shares of Teladoc Health from a "buy" rating to a "hold" rating in a research report on Thursday, May 5th. Credit Suisse Group downgraded shares of Teladoc Health from an "outperform" rating to a "neutral" rating and cut their target price for the stock from $114.00 to $35.00 in a research report on Thursday, April 28th. Finally, StockNews.com raised shares of Teladoc Health to a "sell" rating in a research report on Tuesday, August 9th. Two analysts have rated the stock with a sell rating, twenty-two have given a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, Teladoc Health has an average rating of "Hold" and a consensus target price of $67.90.

Teladoc Health Price Performance

TDOC Stock traded down $3.50 during mid-day trading on Wednesday, hitting $35.95. The company had a trading volume of 6,607,515 shares, compared to its average volume of 6,250,893. The company has a market capitalization of $5.79 billion, a price-to-earnings ratio of -0.60 and a beta of 0.82. Teladoc Health has a 12-month low of $27.38 and a 12-month high of $156.82. The company has a quick ratio of 3.22, a current ratio of 3.38 and a debt-to-equity ratio of 0.25. The company has a 50-day moving average price of $37.03 and a 200 day moving average price of $50.08.

Insiders Place Their Bets

In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the business's stock in a transaction on Friday, June 17th. The shares were sold at an average price of $29.12, for a total value of $29,120.00. Following the sale, the senior vice president now owns 28,408 shares in the company, valued at approximately $827,240.96. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other news, CFO Mala Murthy sold 4,053 shares of the company's stock in a transaction dated Monday, June 27th. The shares were sold at an average price of $37.32, for a total transaction of $151,257.96. Following the sale, the chief financial officer now directly owns 27,295 shares in the company, valued at approximately $1,018,649.40. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Daniel Trencher sold 1,000 shares of the company's stock in a transaction dated Friday, June 17th. The shares were sold at an average price of $29.12, for a total transaction of $29,120.00. Following the sale, the senior vice president now owns 28,408 shares in the company, valued at $827,240.96. The disclosure for this sale can be found here. Insiders have sold a total of 6,053 shares of company stock worth $221,498 in the last 90 days. 1.55% of the stock is currently owned by corporate insiders.

Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

TDOC Stock News Headlines

What's Going On With Teladoc Health Shares Today?
DA Davidson Begins Coverage on Teladoc Health (NYSE:TDOC)
Why Teladoc Crawled Only Marginally Higher on Thursday
StockNews.com Upgrades Teladoc Health (NYSE:TDOC) to Sell
Why Teladoc Might Never Be a Warren Buffett Stock
Is There any Hope for Teladoc Stock in 2023?
Can This Beaten-Down Stock Make a Comeback?
Why Selling Teladoc Right Now Could Be a Huge Mistake
Cowen Lowers Teladoc Health (NYSE:TDOC) to Market Perform
Teladoc Health (NYSE:TDOC) Cut to Market Perform at Cowen
TDOC September 23rd Options Begin Trading
1 Growth Stock Down 76% to Buy and Hold
Teladoc Health (NYSE:TDOC) Lowered to Hold at Berenberg Bank
LAWSUITS FILED AGAINST TDOC, YEXT and U
See More Headlines
Receive TDOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter.

TDOC Company Calendar

Last Earnings
10/27/2021
Today
8/17/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Offices & clinics of medical doctors
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
5,100
Year Founded
2002

Price Target and Rating

Average Stock Price Forecast
$64.83
High Stock Price Forecast
$210.00
Low Stock Price Forecast
$25.00
Forecasted Upside/Downside
+80.3%
Consensus Rating
Hold
Rating Score (0-4)
2.14
Research Coverage
28 Analysts

Profitability

Net Income
$-428,790,000.00
Net Margins
-441.94%
Pretax Margin
-444.04%

Debt

Sales & Book Value

Annual Sales
$2.03 billion
Cash Flow
$0.39 per share
Book Value
$37.75 per share

Miscellaneous

Free Float
158,685,000
Market Cap
$5.79 billion
Optionable
Optionable
Beta
0.82

Social Links


Key Executives














TDOC Stock - Frequently Asked Questions

Should I buy or sell Teladoc Health stock right now?

28 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Teladoc Health in the last twelve months. There are currently 1 sell rating, 22 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" TDOC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TDOC, but not buy additional shares or sell existing shares.
View TDOC analyst ratings
or view top-rated stocks.

What is Teladoc Health's stock price forecast for 2022?

28 analysts have issued 1 year price objectives for Teladoc Health's shares. Their TDOC share price forecasts range from $25.00 to $210.00. On average, they anticipate the company's share price to reach $64.83 in the next twelve months. This suggests a possible upside of 80.3% from the stock's current price.
View analysts price targets for TDOC
or view top-rated stocks among Wall Street analysts.

How have TDOC shares performed in 2022?

Teladoc Health's stock was trading at $91.82 at the beginning of 2022. Since then, TDOC stock has decreased by 60.8% and is now trading at $35.95.
View the best growth stocks for 2022 here
.

When is Teladoc Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our TDOC earnings forecast
.

How were Teladoc Health's earnings last quarter?

Teladoc Health, Inc. (NYSE:TDOC) issued its quarterly earnings results on Wednesday, October, 27th. The health services provider reported ($0.53) earnings per share for the quarter, beating the consensus estimate of ($0.70) by $0.17. The health services provider earned $521.70 million during the quarter, compared to analyst estimates of $516.79 million. Teladoc Health had a negative net margin of 441.94% and a negative trailing twelve-month return on equity of 2.04%. The business's revenue for the quarter was up 80.6% compared to the same quarter last year. During the same period last year, the business posted ($0.13) earnings per share.

What guidance has Teladoc Health issued on next quarter's earnings?

Teladoc Health issued an update on its third quarter 2022 earnings guidance on Thursday, August, 4th. The company provided EPS guidance of -$0.85--$0.60 for the period, compared to the consensus estimate of -$0.55. The company issued revenue guidance of $600.00 million-$620.00 million, compared to the consensus revenue estimate of $613.73 million.

What is Jason Gorevic's approval rating as Teladoc Health's CEO?

106 employees have rated Teladoc Health Chief Executive Officer Jason Gorevic on Glassdoor.com. Jason Gorevic has an approval rating of 95% among the company's employees. This puts Jason Gorevic in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Teladoc Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Teladoc Health investors own include NVIDIA (NVDA), Tesla (TSLA), Alibaba Group (BABA), Advanced Micro Devices (AMD), Block (SQ), Shopify (SHOP), DocuSign (DOCU), Salesforce (CRM), PayPal (PYPL) and Zoom Video Communications (ZM).

When did Teladoc Health IPO?

(TDOC) raised $112 million in an IPO on Wednesday, July 1st 2015. The company issued 7,000,000 shares at a price of $15.00-$17.00 per share. J.P. Morgan and Deutsche Bank Securities served as the underwriters for the IPO and William Blair, Wells Fargo Securities and SunTrust Robinson Humphrey were co-managers.

What is Teladoc Health's stock symbol?

Teladoc Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "TDOC."

Who are Teladoc Health's major shareholders?

Teladoc Health's stock is owned by many different institutional and retail investors. Top institutional investors include Sumitomo Mitsui Trust Holdings Inc. (5.41%), Nikko Asset Management Americas Inc. (5.14%), Baillie Gifford & Co. (4.80%), Renaissance Technologies LLC (2.78%), State of Michigan Retirement System (2.30%) and Himension Capital Singapore PTE. LTD. (1.34%). Insiders that own company stock include Adam C Vandervoort, Andrew Turitz, Arnnon Geshuri, Daniel Trencher, David L Shedlarz, David Travers, David William Sides, Gabriel R Cappucci, Glen Tullman, Hemant Taneja, Jason N Gorevic, Karen L Daniel, Kenneth H Paulus, Lewis Levy, Mala Murthy, Michael Goldstein, Michelle Bucaria, Sandra L Fenwick, Stephany Verstraete, William H Frist and Yulun Wang.
View institutional ownership trends
.

How do I buy shares of Teladoc Health?

Shares of TDOC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Teladoc Health's stock price today?

One share of TDOC stock can currently be purchased for approximately $35.95.

How much money does Teladoc Health make?

Teladoc Health (NYSE:TDOC) has a market capitalization of $5.79 billion and generates $2.03 billion in revenue each year. The health services provider earns $-428,790,000.00 in net income (profit) each year or ($61.40) on an earnings per share basis.

How many employees does Teladoc Health have?

The company employs 5,100 workers across the globe.

Does Teladoc Health have any subsidiaries?
The following companies are subsidiares of Teladoc Health: AM Healthcare Management Consulting Sdn. Bhd., AMHMS - Health Care Management Services S.A., Advance Holdco Limited, Advance Medical, Advance Medical - Serviços de Consultoria e Gestão de Dados Ltda, Advance Medical Health Care Management Services Chile S.A., Advance Medical Hungary Tanácsadó és Szolgáltató Korlátolt Felelösségü Társaság, Advance Medical Inc., AmeriDoc, Best Doctors, Best Doctors Australasia Pty Limited, Best Doctors Holdings Inc., Best Doctors Inc., Best Doctors International Insurance S.a.r.l., Best Doctors Portugal Ltd., BetterHelp, CogCubed, Compile Inc., Consult A Doctor, HY Holdings Inc., Healthiest You, Institute of Patient Safety and Quality in Virtual Care LLC, Intouch Health, Livongo, MedecinDirect, Médecin Direct, Rise Health Inc., Stat Doctors, Stat Health LLC, TELADOC HEALTH INTERNATIONAL SOCIEDAD ANÓNIMA, TelaDietitian, Teladoc Health Canada Inc., Teladoc Health Massachusetts Holdings Inc., Teladoc Health UK Ltd., and Yi Yi Medical Health Management Consulting (Shanghai) Co. Ltd..
Read More
When was Teladoc Health founded?

Teladoc Health was founded in 2002.

How can I contact Teladoc Health?

Teladoc Health's mailing address is 2 MANHATTANVILLE ROAD SUITE 203, PURCHASE NY, 10577. The official website for the company is www.teladochealth.com. The health services provider can be reached via phone at (203) 635-2002 or via email at teladoc@westwicke.com.

This page (NYSE:TDOC) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.